Purple Biotech (PPBT) Other Non-Current Assets (2020 - 2025)

Purple Biotech (PPBT) has 6 years of Other Non-Current Assets data on file, last reported at $5000.0 in Q4 2025.

• Other Non-Current Assets for Q4 2025 came in at $5000.0, down 16.67% year-over-year; the trailing twelve-month figure through Dec 2025 was $5000.0 (down 16.67% YoY), and the FY2025 annual result was $5000.0, down 16.67% from the prior year.
• Other Non-Current Assets fell to $5000.0 in Q4 2025 per PPBT's latest filing, from $28.1 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $28.6 million in Q2 2023 and troughed at $5000.0 in Q4 2025.
• A 5-year average of $10.2 million and a median of $2.9 million in 2021 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2021 and 2023: Other Non-Current Assets plunged 94.79% in 2021, then jumped 983.08% in 2023.
• A 5-year view of Other Non-Current Assets shows it stood at $160000.0 in 2021, then tumbled by 93.75% to $10000.0 in 2022, then plunged by 40.0% to $6000.0 in 2023, then changed by 0.0% to $6000.0 in 2024, then declined by 16.67% to $5000.0 in 2025.
• Business Quant data shows PPBT's Other Non-Current Assets at $5000.0 in Q4 2025, $28.1 million in Q2 2025, and $6000.0 in Q4 2024.